MX2021009554A - Produccion de virus en cultivos celulares. - Google Patents
Produccion de virus en cultivos celulares.Info
- Publication number
- MX2021009554A MX2021009554A MX2021009554A MX2021009554A MX2021009554A MX 2021009554 A MX2021009554 A MX 2021009554A MX 2021009554 A MX2021009554 A MX 2021009554A MX 2021009554 A MX2021009554 A MX 2021009554A MX 2021009554 A MX2021009554 A MX 2021009554A
- Authority
- MX
- Mexico
- Prior art keywords
- cells
- viruses
- relates
- production
- cell culture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16051—Methods of production or purification of viral material
- C12N2760/16052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
- C12N2760/16152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16311—Influenzavirus C, i.e. influenza C virus
- C12N2760/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18211—Henipavirus, e.g. hendra virus
- C12N2760/18251—Methods of production or purification of viral material
Abstract
La presente invención se refiere a métodos de replicar virus in vitro. En particular, la invención se refiere a una población de células modificadas genéticamente y/o a una población de células tratadas con un compuesto exógeno, en donde las células son capaces de producir más virus que las células que carecen de la modificación genética y/o que carecen de un tratamiento con el compuesto exógeno. La invención también se refiere a métodos para producir poblaciones de tales células, así como al uso de los virus obtenidos para preparar composiciones para vacunas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2015904851A AU2015904851A0 (en) | 2015-11-24 | Production of viruses in cell culture |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021009554A true MX2021009554A (es) | 2021-09-08 |
Family
ID=58762866
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018006373A MX2018006373A (es) | 2015-11-24 | 2016-11-23 | Produccion de virus en cultivos celulares. |
MX2021009554A MX2021009554A (es) | 2015-11-24 | 2018-05-23 | Produccion de virus en cultivos celulares. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018006373A MX2018006373A (es) | 2015-11-24 | 2016-11-23 | Produccion de virus en cultivos celulares. |
Country Status (10)
Country | Link |
---|---|
US (3) | US11174466B2 (es) |
EP (1) | EP3380611A4 (es) |
JP (2) | JP7189017B2 (es) |
KR (1) | KR20180081615A (es) |
CN (1) | CN108603188A (es) |
AU (2) | AU2016361455A1 (es) |
BR (1) | BR112018010499A8 (es) |
CA (1) | CA3005989A1 (es) |
MX (2) | MX2018006373A (es) |
WO (1) | WO2017088018A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108884461A (zh) | 2015-11-24 | 2018-11-23 | 联邦科学技术研究组织 | 在禽蛋中产生病毒 |
US11174466B2 (en) | 2015-11-24 | 2021-11-16 | Commonwealth Scientific And Industrial Research Organisation | Production of viruses in cell culture |
US11845989B2 (en) | 2019-01-23 | 2023-12-19 | Regeneron Pharmaceuticals, Inc. | Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors |
JP2022523301A (ja) | 2019-01-23 | 2022-04-22 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | アンジオポエチン様7(angptl7)阻害剤による眼疾患の治療 |
CN110129281A (zh) * | 2019-05-15 | 2019-08-16 | 成都天邦生物制品有限公司 | 一种使用悬浮细胞培养新城疫病毒的方法及应用 |
AU2022226164A1 (en) | 2021-02-26 | 2023-08-03 | Regeneron Pharmaceuticals, Inc. | Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (angptl7) inhibitors |
CN114774418B (zh) * | 2022-04-19 | 2023-11-14 | 深圳市人民医院 | shRNA分子及其在敲低TM9SF2基因表达中的应用 |
CN116656628A (zh) * | 2023-07-31 | 2023-08-29 | 深圳市卫光生物制品股份有限公司 | 一种痘病毒载体疫苗的制备方法 |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5162215A (en) | 1988-09-22 | 1992-11-10 | Amgen Inc. | Method of gene transfer into chickens and other avian species |
WO1999064571A1 (en) * | 1998-06-12 | 1999-12-16 | Mount Sinai School Of Medicine Of The City University Of New York | Interferon inducing genetically engineered attenuated viruses |
US6573079B1 (en) | 1998-06-12 | 2003-06-03 | Mount Sinai School Of Medicine Of New York University | Methods and interferon deficient substrates for the propagation of viruses |
US6599692B1 (en) | 1999-09-14 | 2003-07-29 | Sangamo Bioscience, Inc. | Functional genomics using zinc finger proteins |
US20030104526A1 (en) | 1999-03-24 | 2003-06-05 | Qiang Liu | Position dependent recognition of GNN nucleotide triplets by zinc fingers |
US8202979B2 (en) | 2002-02-20 | 2012-06-19 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid |
US7026462B2 (en) | 2000-12-07 | 2006-04-11 | Sangamo Biosciences, Inc. | Regulation of angiogenesis with zinc finger proteins |
WO2002057308A2 (en) | 2001-01-22 | 2002-07-25 | Sangamo Biosciences, Inc. | Zinc finger polypeptides and their use |
AU2002241946B2 (en) | 2001-01-22 | 2007-04-26 | Sangamo Therapeutics, Inc. | Modified zinc finger binding proteins |
US7145057B2 (en) | 2002-02-01 | 2006-12-05 | Origen Therapeutics, Inc. | Chimeric bird from embryonic stem cells |
WO2005113756A1 (en) | 2004-05-14 | 2005-12-01 | Glaxosmithkline Biologicals S.A. | Method |
CA2595576A1 (en) | 2005-02-01 | 2006-08-10 | Origen Therapeutics, Inc. | Transgenic chickens |
PT2529747T (pt) | 2005-12-02 | 2018-05-09 | Icahn School Med Mount Sinai | Vírus da doença de newcastle quiméricos que apresentam proteínas de superfície não nativas e suas utilizações |
NZ597995A (en) | 2006-12-14 | 2013-05-31 | Dow Agrosciences Llc | Optimized non-canonical zinc finger proteins |
RU2562108C2 (ru) | 2007-09-20 | 2015-09-10 | Коммонвелт Сайентифик Энд Индастриал Рисерч Органайзейшн | Новые цитокины птиц и кодирующие их генетические последовательности |
CA2755192C (en) | 2009-03-20 | 2018-09-11 | Sangamo Biosciences, Inc. | Modification of cxcr4 using engineered zinc finger proteins |
CA2767207A1 (en) | 2009-07-06 | 2011-01-13 | Alnylam Pharmaceuticals, Inc. | Bioprocessing |
US20120178647A1 (en) | 2009-08-03 | 2012-07-12 | The General Hospital Corporation | Engineering of zinc finger arrays by context-dependent assembly |
EP2295543A1 (en) | 2009-09-11 | 2011-03-16 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for the preparation of an influenza virus |
EP2510087A2 (en) | 2009-12-11 | 2012-10-17 | The Brigham and Women's Hospital, Inc. | Pathogen restriction factors |
WO2012164130A1 (es) | 2011-05-27 | 2012-12-06 | Consejo Superior De Investigaciones Científicas (Csic) | Construcción de células deficitarias en un modulador negativo del virus de la gripe para incrementar la producción de virus vacunales |
WO2013059299A1 (en) * | 2011-10-17 | 2013-04-25 | The Uab Research Foundation | Antibodies for interferon subtypes and interferon/interferon receptor ternary complex and uses thereof |
AU2013204327B2 (en) | 2012-04-20 | 2016-09-01 | Aviagen | Cell transfection method |
WO2013166264A2 (en) | 2012-05-02 | 2013-11-07 | University Of Georgia Research Foundation, Inc. | Methods for altering virus replication |
US10000565B2 (en) * | 2012-11-16 | 2018-06-19 | Novartis Ag | Use of IL-1 β binding antibodies for treating peripheral arterial disease |
WO2014123967A2 (en) | 2013-02-05 | 2014-08-14 | University Of Georgia Research Foundation, Inc. | Cell lines for virus production and methods of use |
WO2014142433A1 (ko) | 2013-03-13 | 2014-09-18 | 고려대학교산학협력단 | 바이러스 생산능이 증가된 세포주 및 그 제조방법 |
US9902973B2 (en) | 2013-04-11 | 2018-02-27 | Caribou Biosciences, Inc. | Methods of modifying a target nucleic acid with an argonaute |
GB201310031D0 (en) | 2013-06-05 | 2013-07-17 | Pirbright Inst The | Cell |
GB201310432D0 (en) | 2013-06-12 | 2013-07-24 | Univ St Andrews | Virus Production |
CN104560864B (zh) * | 2014-12-22 | 2017-08-11 | 中国科学院微生物研究所 | 利用CRISPR‑Cas9系统构建的敲除IFN‑β基因的293T细胞系 |
CN104694576B (zh) * | 2015-03-30 | 2018-04-17 | 山东省农业科学院家禽研究所 | 一种沉默df‑1细胞系中ifnar1基因的方法 |
CN108884461A (zh) | 2015-11-24 | 2018-11-23 | 联邦科学技术研究组织 | 在禽蛋中产生病毒 |
US11174466B2 (en) | 2015-11-24 | 2021-11-16 | Commonwealth Scientific And Industrial Research Organisation | Production of viruses in cell culture |
-
2016
- 2016-11-23 US US15/777,890 patent/US11174466B2/en active Active
- 2016-11-23 CA CA3005989A patent/CA3005989A1/en active Pending
- 2016-11-23 BR BR112018010499A patent/BR112018010499A8/pt active Search and Examination
- 2016-11-23 AU AU2016361455A patent/AU2016361455A1/en not_active Abandoned
- 2016-11-23 CN CN201680079158.XA patent/CN108603188A/zh active Pending
- 2016-11-23 MX MX2018006373A patent/MX2018006373A/es unknown
- 2016-11-23 KR KR1020187017660A patent/KR20180081615A/ko not_active Application Discontinuation
- 2016-11-23 EP EP16867451.3A patent/EP3380611A4/en active Pending
- 2016-11-23 JP JP2018526926A patent/JP7189017B2/ja active Active
- 2016-11-23 WO PCT/AU2016/051147 patent/WO2017088018A1/en active Application Filing
-
2018
- 2018-05-23 MX MX2021009554A patent/MX2021009554A/es unknown
-
2019
- 2019-01-25 US US16/258,229 patent/US10626379B2/en active Active
-
2021
- 2021-10-12 US US17/499,509 patent/US20220106574A1/en active Pending
-
2022
- 2022-12-01 JP JP2022193050A patent/JP2023014322A/ja active Pending
-
2023
- 2023-02-03 AU AU2023200556A patent/AU2023200556A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
MX2018006373A (es) | 2018-11-09 |
US10626379B2 (en) | 2020-04-21 |
JP2019500860A (ja) | 2019-01-17 |
CN108603188A (zh) | 2018-09-28 |
US11174466B2 (en) | 2021-11-16 |
AU2023200556A1 (en) | 2023-03-02 |
US20190322989A1 (en) | 2019-10-24 |
AU2016361455A1 (en) | 2018-06-21 |
BR112018010499A8 (pt) | 2019-02-26 |
US20180340153A1 (en) | 2018-11-29 |
WO2017088018A1 (en) | 2017-06-01 |
KR20180081615A (ko) | 2018-07-16 |
EP3380611A4 (en) | 2020-02-12 |
CA3005989A1 (en) | 2017-06-01 |
JP7189017B2 (ja) | 2022-12-13 |
US20220106574A1 (en) | 2022-04-07 |
BR112018010499A2 (pt) | 2018-11-13 |
EP3380611A1 (en) | 2018-10-03 |
JP2023014322A (ja) | 2023-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021009554A (es) | Produccion de virus en cultivos celulares. | |
AU2021209195B2 (en) | Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy | |
MX2018004600A (es) | Celulas aniquiladoras naturales y células ilc3 y usos de las mismas. | |
MX2015001871A (es) | Celulas asesinas naturales y usos de las mismas. | |
MX2023001878A (es) | Celulas modificadas geneticamente que comprenden un gen humano modificado de la region constante alfa del receptor de celulas t. | |
EA201791443A1 (ru) | Естественные киллерные клетки и их применения | |
MX2019007840A (es) | Celulas asesinas naturales modificadas geneticamente. | |
MX2017004890A (es) | Metodos y composiciones para la generación o el mantenimiento de células pluripotentes. | |
MX2022003477A (es) | Medio de cultivo celular complementado con taurina y metodos de uso. | |
WO2016090178A3 (en) | Processes for producing exosomes in reduced oxygen culture conditions | |
PH12017501445A1 (en) | Methods for producing virus for vaccine production | |
BR112016029581A2 (pt) | bactéria geneticamente modificada e métodos de modificação genética de bactéria | |
MX2018010529A (es) | Composiciones y metodos para la produccion y administracion de acido ribonucleico. | |
EP3372685A3 (en) | Cell lines for virus production and methods of use | |
SG10201807208RA (en) | Viral resistant cells and uses thereof | |
NZ703137A (en) | Cells for producing recombinant iduronate-2-sulfatase | |
MX342995B (es) | Métodos de generar células asesinas naturales. | |
MX2017007196A (es) | Fibroblastos de embrion de pollo inmortalizados. | |
PH12021551241A1 (en) | Expansion of natural killer cells and ilc3 cells with novel aromatic compounds | |
WO2017048809A8 (en) | Nk cells exhibiting an adaptive phenotype and methods for preparing and for using | |
IL246525B (en) | Pomegranate cell culture and methods for its preparation and use | |
EA201690232A1 (ru) | Генетически стабильный онколитический рнк вирус, способ его производства и применения | |
EA201891335A1 (ru) | Добавление аргинина с целью повышения эффективности ацетогенов, ферментирующих газ | |
MX2022005790A (es) | Elementos reguladores de planta y metodos para usarlos. | |
NZ708061A (en) | Methods for generating genetically superior animals |